Medicine and Dentistry
Neuropathic Pain
94%
Polyneuropathy
58%
Placebo
55%
Pregabalin
39%
Chronic Inflammatory Demyelinating Polyneuropathy
27%
Lacosamide
27%
Nerve Fiber
24%
Immunoglobulin
23%
Imipramine
23%
Diabetes Mellitus
20%
Infection
20%
Analgesia
19%
Neuropathy
19%
Drug Therapy
18%
Combination Therapy
18%
Drug Response
16%
Randomized Controlled Trial
16%
Anticonvulsant
16%
Antidepressant
16%
Placebo Effect
15%
Monotherapy
14%
Numeric Rating Scale
14%
Diseases
14%
Controlled Clinical Trial
13%
Gabapentin
13%
Skin Biopsy
13%
Confocal Microscopy
13%
Cannabidiol
13%
Cannabinol
13%
Paraneoplastic Syndrome
13%
Carbon Tetrachloride
13%
Diabetic Neuropathy
12%
Weakness
11%
Quantitative Sensory Testing
9%
Venlafaxine
9%
Escitalopram
9%
Oxcarbazepine
9%
Physical Disease by Body Function
8%
Clinical Trial
8%
Serotonin-Norepinephrine Reuptake Inhibitor
8%
Tricyclic Antidepressant
7%
Drug Megadose
7%
Side Effect
7%
Autonomic Dysfunction
6%
Deterioration
6%
Bulbar Palsy
6%
Cancer
6%
Pembrolizumab
6%
Diabetes
6%
Nociceptor
5%
Pharmacology, Toxicology and Pharmaceutical Science
Neuropathic Pain
100%
Placebo
92%
Polyneuropathy
71%
Pregabalin
53%
Imipramine
36%
Anticonvulsive Agent
33%
Levetiracetam
32%
Lacosamide
27%
Combination Therapy
23%
Monotherapy
18%
Randomized Controlled Trial
16%
Antidepressant
16%
Multiple Sclerosis
13%
Controlled Clinical Trial
13%
Carbon Tetrachloride
13%
Cannabidiol
13%
Syndrome
13%
Infection
13%
Chronic Inflammatory Demyelinating Polyneuropathy
13%
Drug Concentration
13%
Immunoglobulin
13%
Gabapentin
13%
Physical Disease by Body Function
10%
Oxcarbazepine
9%
Venlafaxine
9%
Escitalopram
9%
Clinical Trial
8%
Serotonin-Norepinephrine Reuptake Inhibitor
8%
Tricyclic Antidepressant
7%
Side Effect
7%
Diabetes Mellitus
6%
Deterioration
6%
Selective Serotonin Reuptake Inhibitor
5%
Neuroscience
Polyneuropathy
98%
Neuropathic Pain
86%
Placebo
82%
Imipramine
31%
Randomized Controlled Trial
30%
Lacosamide
27%
Pregabalin
25%
Intravenous Immunoglobulin
23%
Nerve Fiber
21%
Diabetes Mellitus
20%
Neuropathy
20%
Antidepressant
16%
Anticonvulsant
16%
Pain Studies
13%
Confocal Microscopy
13%
Agonist
13%
Cytomegalovirus
13%
Terbutaline
13%
Drug Therapy
13%
Diabetic Neuropathy
12%
Quantitative Sensory Testing
9%
Escitalopram
9%
Venlafaxine
9%
Oxcarbazepine
9%
Tricyclic Antidepressant
7%
Hepatitis E Virus
6%
Epstein-Barr Virus
6%
Nociceptor
5%
